- Home
- EFSH vs TOI Comparison
EFSH vs TOI Comparison
Compare EFSH & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFSH
- TOI
- Stock Information
- Founded
- EFSH 1948
- TOI 2007
- Country
- EFSH United States
- TOI United States
- Employees
- EFSH N/A
- TOI N/A
- Industry
- EFSH Professional Services
- TOI Medical/Nursing Services
- Sector
- EFSH Consumer Discretionary
- TOI Health Care
- Exchange
- EFSH Nasdaq
- TOI Nasdaq
- Market Cap
- EFSH 17.4M
- TOI 20.1M
- IPO Year
- EFSH N/A
- TOI N/A
- Fundamental
- Price
- EFSH $0.52
- TOI $0.18
- Analyst Decision
- EFSH
- TOI Strong Buy
- Analyst Count
- EFSH 0
- TOI 1
- Target Price
- EFSH N/A
- TOI $2.50
- AVG Volume (30 Days)
- EFSH 3.6M
- TOI 297.4K
- Earning Date
- EFSH 11-26-2024
- TOI 11-13-2024
- Dividend Yield
- EFSH N/A
- TOI N/A
- EPS Growth
- EFSH N/A
- TOI N/A
- EPS
- EFSH N/A
- TOI N/A
- Revenue
- EFSH $68,768,978.00
- TOI $378,933,000.00
- Revenue This Year
- EFSH N/A
- TOI $29.17
- Revenue Next Year
- EFSH N/A
- TOI $16.43
- P/E Ratio
- EFSH N/A
- TOI N/A
- Revenue Growth
- EFSH 26.67
- TOI 22.29
- 52 Week Low
- EFSH $0.44
- TOI $0.18
- 52 Week High
- EFSH $1,037.40
- TOI $2.50
- Technical
- Relative Strength Index (RSI)
- EFSH 39.55
- TOI 24.09
- Support Level
- EFSH $0.44
- TOI $0.25
- Resistance Level
- EFSH $0.75
- TOI $0.30
- Average True Range (ATR)
- EFSH 1.14
- TOI 0.04
- MACD
- EFSH -0.74
- TOI -0.01
- Stochastic Oscillator
- EFSH 0.78
- TOI -0.06
About EFSH 1847 Holdings LLC
1847 Holdings LLC is a diversified holding company. It operates in Four segments: Retail and appliances, Retail and Eyewear, Construction, and Automotive Supplies. The company generates maximum revenue from the Construction segment. The firm, through its subsidiaries, provides a wide range of land application services and sells equipment and parts, primarily to the agricultural, construction, and lawn and garden industries.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.